Traditional combination ART consists of 2 nucleoside reverse transcriptase inhibitors + 1 protease inhibitor; this prospective study of 274 pregnant women infected with HIV compared their viral load near delivery after receiving traditional cART.
Retrospective chart reviews were conducted for Black, genotype 1 (GT1), HIV/HCV co-infected patients treated with ledipasvir/sofosbuvir (LDV/SOF) at 3 hospitals.
The researchers compared the effectiveness of oral beta-lactams to fluoroquinolones in the treatment of Enterobacteriaceae bloodstream infections (EBSI) in adult patients.
Intravenous (IV) antibiotics such as CPT is indicated for ABSSSIs “but real world clinical comparative data is limited.”
Prophylaxis against mycobacterium avium-intracellulare complex (MAC) is recommended for patients with CD4 counts of 3.
The authors gathered clinical and demographic data from the University of Kentucky Center for Clinical and Translational Science Enterprise Data Trust, for adults who received TZP+VAN or CFP+VAN for ≥48 hours in the ICU.
To investigate the efficacy of telavancin in the treatment of bacteremia and infective endocarditis, the authors looked at data from the Telavancin Observational Use Registry, which reports on outcomes of patients treated with telavancin in clinical practice.
A total of 1,042 patients with infection were randomly assigned to receive either intravenous/oral DLX monotherapy or VAN (15mg/kg) with AZ for 5 to 14 days.
The study authors sought to contribute to the evidence base on gender differences in virologic and immunologic responses to ART in treatment-naïve individuals.
Participants included 464 hospitalized adults with cUTI or AP diagnosis, randomly assigned to be administered either ZTI-01 or piperacillin/tazobactam for a fixed 7 days.
